My Account
Follow us on:
Powered By
See the top gainers, losers, invest and get updated what's happening in the crypto market
Invest Now
Discover the secret world of unlisted shares — analyse India's top pre-IPO companies and invest before they hit the markets
Hellen De Kloet, Biz Head-Western Europe & ANZ, Sun Pharma said the launch of ‘Gemcitabine InfuSMART‘ will start in the UK and the Netherlands because these are the first two countries in Europe where we have final approval.
You are already a Moneycontrol Pro user.